Search research articles
Contact Us
Filters
Showing results (131-140 of 187) with videos related to
Page
of 19
Sort By:
Clinical Practice (London, England)
|
August 25, 2023
Identification of 2 large size HCC phenotypes, with and without associated inflammation
Brian I Carr, Harika Gozukara Bag, Hikmet Akkiz, et al.
Clinical Practice (London, England)
|
May 11, 2021
CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation
Brian I Carr, Volkan Ince, Harika Gozukara Bag, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
June 18, 2014
Modulation of Doxorubicin mediated growth inhibition of hepatocellular carcinoma cells by platelet lysates
Maria Grazia Refolo, Rosalba D'Alessandro, Catia Lippolis, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|
September 8, 2023
Liver Transplantation for Hepatocellular Carcinoma in Patients with Inherited Metabolic Liver Diseases: A Single-Center Analysis
İbrahim Umar Garzali, Abdirahman Sakulen Hargura, Volkan İnce, et al.
Journal of Gastroenterology and Hepatology
|
May 15, 2015
Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients
Antonio Facciorusso, Valentina Del Prete, Nicola Crucinio, et al.
Journal of Gastrointestinal Cancer
|
November 15, 2012
Systemic treatment of gastrointestinal cancer in elderly patients
Silvana Leo, Caterina Accettura, Antonio Gnoni, et al.
Cancer
|
February 6, 2003
Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma
Osama M Ebied, Michael P Federle, Brian I Carr, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 18, 2005
90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT
Maren Bienert, Barry McCook, Brian I Carr, et al.
BMC Cancer
|
June 3, 2014
Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines
Rosalba D'Alessandro, Maria G Refolo, Catia Lippolis, et al.
Investigational New Drugs
|
May 4, 2005
Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy
Dean Lim, Robert J Morgan, Steven Akman, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 187) with videos related to
Sort By:
Page
of 19
Clinical Practice (London, England)
|
August 25, 2023
Identification of 2 large size HCC phenotypes, with and without associated inflammation
Brian I Carr, Harika Gozukara Bag, Hikmet Akkiz, et al.
Clinical Practice (London, England)
|
May 11, 2021
CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation
Brian I Carr, Volkan Ince, Harika Gozukara Bag, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
June 18, 2014
Modulation of Doxorubicin mediated growth inhibition of hepatocellular carcinoma cells by platelet lysates
Maria Grazia Refolo, Rosalba D'Alessandro, Catia Lippolis, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|
September 8, 2023
Liver Transplantation for Hepatocellular Carcinoma in Patients with Inherited Metabolic Liver Diseases: A Single-Center Analysis
İbrahim Umar Garzali, Abdirahman Sakulen Hargura, Volkan İnce, et al.
Journal of Gastroenterology and Hepatology
|
May 15, 2015
Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients
Antonio Facciorusso, Valentina Del Prete, Nicola Crucinio, et al.
Journal of Gastrointestinal Cancer
|
November 15, 2012
Systemic treatment of gastrointestinal cancer in elderly patients
Silvana Leo, Caterina Accettura, Antonio Gnoni, et al.
Cancer
|
February 6, 2003
Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma
Osama M Ebied, Michael P Federle, Brian I Carr, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 18, 2005
90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT
Maren Bienert, Barry McCook, Brian I Carr, et al.
BMC Cancer
|
June 3, 2014
Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines
Rosalba D'Alessandro, Maria G Refolo, Catia Lippolis, et al.
Investigational New Drugs
|
May 4, 2005
Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy
Dean Lim, Robert J Morgan, Steven Akman, et al.
Page
of 19